SNY Q1 2026 Earnings EPS Surpasses Estimates by 407 Stock Edges Lower Janux Therapeutics Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid Continued Pipeline Progress BXMT Q1 2026 Earnings Significant EPS Miss as Credit Market Challenges Weigh on Results CNVS Q1 2026 Earnings NarrowerThanExpected Loss Revenue Data Unavailable TX Q1 2026 Earnings Strong Earnings Beat Despite Revenue Uncertainty Stock Slightly Down EFSCP Q1 2026 Earnings EPS Misses Estimates Preferred Shares Dip Cartesian Therapeutics RNAC Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage